Blood transcriptomic markers in patients with late-onset major depressive disorder

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Miyata, Shigeo ^a   Kurachi, Masashi ^a   Okano, Yoshiko ^a   Sakurai, Noriko ^a   Kobayashi, Ayumi ^b   Harada, Kenichiro ^b   Yamagata, Hirotaka ^b   Matsuo, Koji ^b   Takahashi, Keisuke ^a   Narita, Kosuke ^a   Fukuda, Masato ^a   Ishizaki, Yasuki ^a   Mikuni, Masahiko ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL; CIDEC GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DISCRIMINANT VALIDITY; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; LATE ONSET MAJOR DEPRESSIVE DISORDER; MAJOR DEPRESSION; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNASE1 GENE; SENSITIVITY AND SPECIFICITY; SLC36A1 GENE; STYXL1 GENE; TRANSCRIPTOMICS; ANIMAL; ANIMAL BEHAVIOR; BLOOD; COHORT ANALYSIS; EMOTION; GENETIC MARKER; GENETICS; MIDDLE AGED; ONSET AGE;

GENETIC MARKER; TRANSCRIPTOME;

AGE OF ONSET; AGED; ANIMALS; BEHAVIOR, ANIMAL; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; EMOTIONS; FEMALE; GENETIC MARKERS; HUMANS; MALE; MICE; MIDDLE AGED; TRANSCRIPTOME;

EID: 84960448882     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150262     Document Type: Article

References (62)

1. Sato S, Yeh TL. Challenges in treating patients with major depressive disorder: the impact of biological and social factors. CNS Drugs. 2013; 27 Suppl 1:S5-10. Epub 2013/05/29. doi: 10.1007/s40263-012- 0028-8 PMID: 23712795.
2. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2129-43. Epub 2012/12/19. doi: 10.1016/s0140- 6736(12)61680-8 PMID: 23245605.
3. Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet. 2012; 379(9820):1045-55. Epub 2011/12/23. doi: 10.1016/s0140-6736(11) 60602-8 PMID: 22189047; PubMed Central PMCID: PMCPmc3397431.
4. Fekadu A, Wooderson SC, Markopoulo K, Donaldson C, Papadopoulos A, Cleare AJ. What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. Journal of affective disorders. 2009; 116(1-2):4-11. Epub 2008/11/15. doi: 10.1016/j.jad.2008.10.014 PMID: 19007996.
5. Davidson JR, Meltzer-Brody SE. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem? The Journal of clinical psychiatry. 1999; 60 Suppl 7:4-9; discussion 10-1. Epub 1999/05/18. PMID: 10326869.
6. Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA: the journal of the American Medical Association. 2010; 303(1):47-53. Epub 2010/01/07. doi: 10.1001/jama.2009.1943 PMID: 20051569; PubMed Central PMCID: PMCPmc3712503.
7. Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. The Journal of clinical psychiatry. 2000; 61(10):804-8; quiz 9. Epub 2000/11/15. PMID: 11078046.
8. Sharma V, Khan M, Smith A. A closer look at treatment resistant depression: is it due to a bipolar diathesis? Journal of affective disorders. 2005; 84(2-3):251-7. Epub 2005/02/15. doi: 10.1016/j.jad.2004.01. 015 PMID: 15708423.
9. Chan MK, Gottschalk MG, Haenisch F, Tomasik J, Ruland T, Rahmoune H, et al. Applications of bloodbased protein biomarker strategies in the study of psychiatric disorders. Progress in neurobiology. 2014; 122:45-72. Epub 2014/09/01. doi: 10.1016/j.pneurobio.2014.08.002 PMID: 25173695.
10. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ, et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Molecular psychiatry. 2009; 14 (2):156-74. Epub 2008/02/28. doi: 10.1038/mp.2008.11 PMID: 18301394.
11. Hepgul N, Cattaneo A, Zunszain PA, Pariante CM. Depression pathogenesis and treatment: what can we learn from blood mRNA expression? BMC medicine. 2013; 11:28. Epub 2013/02/07. doi: 10.1186/1741-7015-11-28 PMID: 23384232; PubMed Central PMCID: PMCPmc3606439.
12. Glatt SJ, Tsuang MT, Winn M, Chandler SD, Collins M, Lopez L, et al. Blood-based gene expression signatures of infants and toddlers with autism. Journal of the American Academy of Child and Adolescent Psychiatry. 2012; 51(9):934-44.e2. Epub 2012/08/25. doi: 10.1016/j.jaac.2012.07.007 PMID: 22917206; PubMed Central PMCID: PMCPmc3756503.
13. Tsuang MT, Nossova N, Yager T, Tsuang MM, Guo SC, Shyu KG, et al. Assessing the validity of bloodbased gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. 2005; 133b(1):1-5. Epub 2005/01/13. doi: 10.1002/ajmg.b.30161 PMID: 15645418.
14. Zhang Y, Yao L, Liu W, Li W, Tian C, Wang ZY, et al. Bioinformatics analysis raises candidate genes in blood for early screening of Parkinson's disease. Biomedical and environmental sciences: BES. 2014; 27(6):462-5. Epub 2014/06/26. doi: 10.3967/bes2014.074 PMID: 24961856.
15. Segman RH, Goltser-Dubner T, Weiner I, Canetti L, Galili-Weisstub E, Milwidsky A, et al. Blood mononuclear cell gene expression signature of postpartum depression. Molecular psychiatry. 2010; 15 (1):93-100, 2. Epub 2009/07/08. doi: 10.1038/mp.2009.65 PMID: 19581911.
16. Yi Z, Li Z, Yu S, Yuan C, Hong W, Wang Z, et al. Blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder. PloS one. 2012; 7 (2):e31283. Epub 2012/02/22. doi: 10.1371/journal.pone.0031283 PMID: 22348066; PubMed Central PMCID: PMCPmc3278427.
17. Redei EE, Andrus BM, Kwasny MJ, Seok J, Cai X, Ho J, et al. Blood transcriptomic biomarkers in adult primary care patients with major depressive disorder undergoing cognitive behavioral therapy. Translational psychiatry. 2014; 4:e442. Epub 2014/09/17. doi: 10.1038/tp.2014.66 PMID: 25226551; PubMed Central PMCID: PMCPmc4198533.
18. Redei EE, Mehta NS. Blood transcriptomic markers for major depression: from animal models to clinical settings. Annals of the New York Academy of Sciences. 2015; 1344(1):37-49. Epub 2015/04/01. doi: 10.1111/nyas.12748 PMID: 25823952.
19. Belzeaux R, Bergon A, Jeanjean V, Loriod B, Formisano-Treziny C, Verrier L, et al. Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Translational psychiatry. 2012; 2:e185. Epub 2012/11/15. doi: 10.1038/tp.2012.112 PMID: 23149449; PubMed Central PMCID: PMCPmc3565773.
20. Hayashi-Takagi A, Vawter MP, Iwamoto K. Peripheral biomarkers revisited: integrative profiling of peripheral samples for psychiatric research. Biological psychiatry. 2014; 75(12):920-8. Epub 2013/11/30. doi: 10.1016/j.biopsych.2013.09.035 PMID: 24286759.
21. Keri S, Szabo C, Kelemen O. Blood biomarkers of depression track clinical changes during cognitivebehavioral therapy. Journal of affective disorders. 2014; 164:118-22. Epub 2014/05/27. doi: 10.1016/j. jad.2014.04.030 PMID: 24856564.
22. Park SC, Hahn SW, Hwang TY, Kim JM, Jun TY, Lee MS, et al. Does age at onset of first major depressive episode indicate the subtype of major depressive disorder?: the clinical research center for depression study. Yonsei Med J. 2014; 55(6):1712-20. Epub 2014/10/18. doi: 10.3349/ymj.2014.55.6.1712 PMID: 25323911; PubMed Central PMCID: PMCPMC4205714.
23. Hu C, Geng Y, Feng Y, Wang G, Ungvari GS, Chiu HF, et al. Demographic and clinical differences between early- and late-onset major depressions in thirteen psychiatric institutions in China. Journal of affective disorders. 2015; 170:266-9. Epub 2014/09/30. doi: 10.1016/j.jad.2014.09.008 PMID: 25265534.
24. Zisook S, Rush AJ, Albala A, Alpert J, Balasubramani GK, Fava M, et al. Factors that differentiate early vs. later onset of major depression disorder. Psychiatry research. 2004; 129(2):127-40. Epub 2004/12/14. doi: 10.1016/j.psychres.2004.07.004 PMID: 15590040.
25. Janssen J, Beekman AT, Comijs HC, Deeg DJ, Heeren TJ. Late-life depression: the differences between early- and late-onset illness in a community-based sample. International journal of geriatric psychiatry. 2006; 21(1):86-93. Epub 2005/12/03. doi: 10.1002/gps.1428 PMID: 16323255.
26. Korten NC, Comijs HC, Lamers F, Penninx BW. Early and late onset depression in young and middle aged adults: differential symptomatology, characteristics and risk factors? Journal of affective disorders. 2012; 138(3):259-67. Epub 2012/03/01. doi: 10.1016/j.jad.2012.01.042 PMID: 22370067.
27. Kendler KS, Fiske A, Gardner CO, Gatz M. Delineation of two genetic pathways to major depression. Biological psychiatry. 2009; 65(9):808-11. Epub 2008/12/24. doi: 10.1016/j.biopsych.2008.11.015 PMID: 19103442; PubMed Central PMCID: PMCPmc2744314.
28. Power RA, Keers R, Ng MY, Butler AW, Uher R, Cohen-Woods S, et al. Dissecting the genetic heterogeneity of depression through age at onset. American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. 2012; 159b (7):859-68. Epub 2012/08/24. doi: 10.1002/ajmg.b.32093 PMID: 22915352.
29. Naismith SL, Norrie LM, Mowszowski L, Hickie IB. The neurobiology of depression in later-life: clinical, neuropsychological, neuroimaging and pathophysiological features. Progress in neurobiology. 2012; 98(1):99-143. Epub 2012/05/23. doi: 10.1016/j.pneurobio.2012.05.009 PMID: 22609700.
30. Muhonen LH, Lonnqvist J, Lahti J, Alho H. Age at onset of first depressive episode as a predictor for escitalopram treatment of major depression comorbid with alcohol dependence. Psychiatry research. 2009; 167(1-2):115-22. Epub 2009/04/07. doi: 10.1016/j.psychres.2008.05.001 PMID: 19346004.
31. Sung SC, Wisniewski SR, Balasubramani GK, Zisook S, Kurian B, Warden D, et al. Does early-onset chronic or recurrent major depression impact outcomes with antidepressant medications? A CO-MED trial report. Psychological medicine. 2013; 43(5):945-60. Epub 2012/12/12. doi: 10.1017/s0033291712001742 PMID: 23228340.
32. Pajer K, Andrus BM, Gardner W, Lourie A, Strange B, Campo J, et al. Discovery of blood transcriptomic markers for depression in animal models and pilot validation in subjects with early-onset major depression. Translational psychiatry. 2012; 2:e101. Epub 2012/07/27. doi: 10.1038/tp.2012.26 PMID: 22832901; PubMed Central PMCID: PMCPmc3337072.
33. Pereira PA, Bicalho MA, de Moraes EN, Malloy-Diniz L, Bozzi IC, Nicolato R, et al. Genetic variant of AKT1 and AKTIP associated with late-onset depression in a Brazilian population. International journal of geriatric psychiatry. 2014; 29(4):399-405. Epub 2013/09/12. doi: 10.1002/gps.4018 PMID: 24022875.
34. Zhang L, Li H, Hu X, Benedek DM, Fullerton CS, Forsten RD, et al. Mitochondria-focused gene expression profile reveals common pathways and CPT1B dysregulation in both rodent stress model and human subjects with PTSD. Translational psychiatry. 2015; 5:e580. Epub 2015/06/17. doi: 10.1038/tp. 2015.65 PMID: 26080315; PubMed Central PMCID: PMCPmc4490278.
35. Uchida S, Hara K, Kobayashi A, Otsuki K, Yamagata H, Hobara T, et al. Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron. 2011; 69 (2):359-72. Epub 2011/01/26. doi: 10.1016/j.neuron.2010.12.023 PMID: 21262472.
36. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, Kamps WA, et al. Evidence based selection of housekeeping genes. PloS one. 2007; 2(9):e898. Epub 2007/09/20. doi: 10.1371/journal. pone.0000898 PMID: 17878933; PubMed Central PMCID: PMCPMC1976390.
37. Cho P, Schneider GB, Krizan K, Keller JC. Examination of the bone-implant interface in experimentally induced osteoporotic bone. Implant Dent. 2004; 13(1):79-87. Epub 2004/03/17. PMID: 15017309.
38. Liu ML, Xu X, Rang WQ, Li YJ, Song HP. Influence of ovariectomy and 17beta-estradiol treatment on insulin sensitivity, lipid metabolism and post-ischemic cardiac function. Int J Cardiol. 2004; 97(3):485-93. Epub 2004/11/25. doi: 10.1016/j.ijcard.2003.11.046 PMID: 15561337.
39. Nakagawasai O, Oba A, Sato A, Arai Y, Mitazaki S, Onogi H, et al. Subchronic stress-induced depressive behavior in ovariectomized mice. Life sciences. 2009; 84(15-16):512-6. Epub 2009/03/24. doi: 10.1016/j.lfs.2009.01.009 PMID: 19302813.
40. Lagunas N, Calmarza-Font I, Diz-Chaves Y, Garcia-Segura LM. Long-term ovariectomy enhances anxiety and depressive-like behaviors in mice submitted to chronic unpredictable stress. Hormones and behavior. 2010; 58(5):786-91. Epub 2010/08/10. doi: 10.1016/j.yhbeh.2010.07.014 PMID: 20691693.
41. Seeman MV. Psychopathology in women and men: focus on female hormones. The American journal of psychiatry. 1997; 154(12):1641-7. Epub 1997/12/16. PMID: 9396940.
42. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. The British journal of psychiatry: the journal of mental science. 2013; 202(5):329-35. Epub 2013/05/03. doi: 10.1192/bjp.bp.112.118307 PMID: 23637108; PubMed Central PMCID: PMCPmc3640214.
43. Liu Z, Li X, Sun N, Xu Y, Meng Y, Yang C, et al. Microarray profiling and co-expression network analysis of circulating lncRNAs and mRNAs associated with major depressive disorder. PloS one. 2014; 9(3): e93388. Epub 2014/03/29. doi: 10.1371/journal.pone.0093388 PMID: 24676134; PubMed Central PMCID: PMCPmc3968145.
44. Guilloux JP, Bassi S, Ding Y, Walsh C, Turecki G, Tseng G, et al. Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology. 2015; 40 (3):701-10. Epub 2014/09/02. doi: 10.1038/npp.2014.226 PMID: 25176167; PubMed Central PMCID: PMCPmc4289958.
45. Inohara N, Koseki T, Chen S, Wu X, Nunez G. CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. The EMBO journal. 1998; 17(9):2526-33. Epub 1998/06/20. doi: 10.1093/emboj/17.9.2526 PMID: 9564035; PubMed Central PMCID: PMCPmc1170594.
46. Liang L, Zhao M, Xu Z, Yokoyama KK, Li T. Molecular cloning and characterization of CIDE-3, a novel member of the cell-death-inducing DNA-fragmentation-factor (DFF45)-like effector family. The Biochemical journal. 2003; 370(Pt 1):195-203. Epub 2002/11/14. doi: 10.1042/bj20020656 PMID: 12429024; PubMed Central PMCID: PMCPmc1223158.
47. Yonezawa T, Kurata R, Kimura M, Inoko H. Which CIDE are you on? Apoptosis and energy metabolism. Molecular bioSystems. 2011; 7(1):91-100. Epub 2010/10/23. doi: 10.1039/c0mb00099j PMID: 20967381.
48. Ito M, Nagasawa M, Omae N, Ide T, Akasaka Y, Murakami K. Differential regulation of CIDEA and CIDEC expression by insulin via Akt1/2- and JNK2-dependent pathways in human adipocytes. Journal of lipid research. 2011; 52(8):1450-60. Epub 2011/06/04. doi: 10.1194/jlr.M012427 PMID: 21636835; PubMed Central PMCID: PMCPmc3137012.
49. Nishino N, Tamori Y, Tateya S, Kawaguchi T, Shibakusa T, Mizunoya W, et al. FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. The Journal of clinical investigation. 2008; 118(8):2808-21. Epub 2008/07/26. doi: 10.1172/jci34090 PMID: 18654663; PubMed Central PMCID: PMCPmc2483680.
50. Sorrentino S. Human extracellular ribonucleases: multiplicity, molecular diversity and catalytic properties of the major RNase types. Cellular and molecular life sciences: CMLS. 1998; 54(8):785-94. Epub 1998/10/07. PMID: 9760987.
51. Yasuda T, Nadano D, Takeshita H, Kishi K. Two distinct secretory ribonucleases from human cerebrum: purification, characterization and relationships to other ribonucleases. The Biochemical journal. 1993; 296 (Pt 3):617-25. Epub 1993/12/15. PMID: 8280059; PubMed Central PMCID: PMCPmc1137742.
52. Mizuta K, Awazu S, Yasuda T, Kishi K. Purification and characterization of three ribonucleases from human kidney: comparison with urine ribonucleases. Archives of biochemistry and biophysics. 1990; 281(1):144-51. Epub 1990/08/15. PMID: 2383019.
53. Landre JB, Hewett PW, Olivot JM, Friedl P, Ko Y, Sachinidis A, et al. Human endothelial cells selectively express large amounts of pancreatic-type ribonuclease (RNase 1). Journal of cellular biochemistry. 2002; 86(3):540-52. Epub 2002/09/05. doi: 10.1002/jcb.10234 PMID: 12210760.
54. Fischer S, Nishio M, Dadkhahi S, Gansler J, Saffarzadeh M, Shibamiyama A, et al. Expression and localisation of vascular ribonucleases in endothelial cells. Thrombosis and haemostasis. 2011; 105 (2):345-55. Epub 2010/11/26. doi: 10.1160/th10-06-0345 PMID: 21103661.
55. Gansler J, Preissner KT, Fischer S. Influence of proinflammatory stimuli on the expression of vascular ribonuclease 1 in endothelial cells. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2014; 28(2):752-60. Epub 2013/11/01. doi: 10.1096/fj.13-238600 PMID: 24174426.
56. Maciejak A, Kiliszek M, Michalak M, Tulacz D, Opolski G, Matlak K, et al. Gene expression profiling reveals potential prognostic biomarkers associated with the progression of heart failure. Genome medicine. 2015; 7(1):26. Epub 2015/05/20. doi: 10.1186/s13073-015-0149-z PMID: 25984239; PubMed Central PMCID: PMCPmc4432772.
57. Thwaites DT, Anderson CM. The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport. Br J Pharmacol. 2011; 164(7):1802-16. Epub 2011/04/20. doi: 10.1111/j.1476-5381.2011.01438.x PMID: 21501141; PubMed Central PMCID: PMCPMC3246705.
58. Nielsen CU, Frolund S, Abdulhadi S, Sari H, Langthaler L, Nohr MK, et al. Sertraline inhibits the transport of PAT1 substrates in vivo and in vitro. Br J Pharmacol. 2013; 170(5):1041-52. Epub 2013/08/22. doi: 10.1111/bph.12341 PMID: 23962042; PubMed Central PMCID: PMCPmc3949652.
59. Do TT, Hindlet P, Waligora-Dupriet AJ, Kapel N, Neveux N, Mignon V, et al. Disturbed intestinal nitrogen homeostasis in a mouse model of high-fat diet-induced obesity and glucose intolerance. American journal of physiology Endocrinology and metabolism. 2014; 306(6):E668-80. Epub 2014/01/16. doi: 10.1152/ajpendo.00437.2013 PMID: 24425764.
60. Walker DK, Drummond MJ, Dickinson JM, Borack MS, Jennings K, Volpi E, et al. Insulin increases mRNA abundance of the amino acid transporter SLC7A5/LAT1 via an mTORC1-dependent mechanism in skeletal muscle cells. Physiological reports. 2014; 2(3):e00238. Epub 2014/04/25. doi: 10.1002/phy2.238 PMID: 24760501; PubMed Central PMCID: PMCPmc4002227.
61. Niemi NM, Lanning NJ, Klomp JA, Tait SW, Xu Y, Dykema KJ, et al. MK-STYX, a catalytically inactive phosphatase regulating mitochondrially dependent apoptosis. Molecular and cellular biology. 2011; 31 (7):1357-68. Epub 2011/01/26. doi: 10.1128/mcb.00788-10 PMID: 21262771; PubMed Central PMCID: PMCPmc3135289.
62. Isrie M, Zamani Esteki M, Peeters H, Voet T, Van Houdt J, Van PaesschenW, et al. Homozygous missense mutation in STYXL1 associated with moderate intellectual disability, epilepsy and behavioural complexities. European journal of medical genetics. 2015; 58(4):205-10. Epub 2015/03/01. doi: 10.1016/j.ejmg.2015.02.006 PMID: 25724587.